NASDAQ · DBVT
DBV Technologies S.A.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for DBVT has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.65 | $-0.65 | $-0.65 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · The Motley Fool · MarketBeat- RTTNews · Oct 29, 5:49 AM EDTDBV Technologies Report Wider Q3 Loss, Advances Peanut Allergy Patch Toward Potential Launch(RTTNews) – DBV Technologies (DBVT) reported a wider third-quarter 2026 net loss as it increased spending on clinical development, regulatory submissions and commercial preparations for its VIASKIN Peanut Patch.
- Fintel · Oct 29, 4:28 AM EDTDBV Technologies S.A. Reports Third Quarter 2026 Financial ResultsDBV Technologies S.A. reported its financial results for the third quarter ended September 30, 2026. The company recorded operating income of $1.6 million for the three months ended September 30, 2026, compared with $2.8 million for the same period in 2025. Net loss for the third
- The Motley Fool · Oct 29, 1:13 AM EDTDBV Technologies (DBVT) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Oct 28, 8:04 PM EDTWhat DBV Technologies (DBVT) Said on Its Q3 Earnings Call3 Biopharmaceutical Stocks Bucking the Sell-OffDBV Technologies (NASDAQ:DBVT) said it submitted a biologics license application, or BLA, to the U.S. Food and Drug Administration for its VIASKIN Peanut patch in children ages 4 to 7, while continuing preparations for a potential co
- RTTNews · Sep 30, 1:20 AM EDTDBV Seeks FDA Approval For VIASKIN Peanut Patch In Young Children(RTTNews) – DBV Technologies (DBVT) announced that it has submitted a Biologics License Application to the U.S. FDA for the VIASKIN Peanut Patch in children aged 4 through 7 years with peanut allergy. The company has requested Priority Review of the application.
- RTTNews · Sep 29, 11:24 PM EDTDBV Submits BLA For VIASKIN Peanut Patch In Children With Peanut Allergy(RTTNews) – DBV Technologies (DBVT) announced the submission of a Biologics License Application to the U.S. FDA for the VIASKIN Peanut Patch in children aged 4 to 7 years with peanut allergy.
- MarketBeat · Jul 16, 7:03 PM EDTDBV Technologies Q2 Earnings Call Highlights3 Biopharmaceutical Stocks Bucking the Sell-OffDBV Technologies (NASDAQ:DBVT) said it is continuing preparations for a planned third-quarter 2026 Biologics License Application submission for its VIASKIN Peanut Patch in children ages 4 through 7, while also building commercial inf
- Zacks · Jun 15, 7:59 AM EDTDBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?DBV Technologies (DBVT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Zacks · Apr 24, 9:40 AM EDTIs COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year?Here is how COMPASS Pathways PLC Sponsored ADR (CMPS) and DBV Technologies S.A. (DBVT) have performed compared to their sector so far this year.
- Fintel · Apr 15, 10:48 PM EDTDBV Technologies S.A. – Depositary Receipt (DBVT) Price Target Increased by 32.54% to 31.33The average one-year price target for DBV Technologies S.A. – Depositary Receipt (NasdaqCM:DBVT) has been revised to $31.33 / share. This is an increase of 32.54% from the prior estimate of $23.64 dated April 9, 2026. The price target is an average of many tar
- Zacks · Apr 14, 12:00 PM EDTDBV Technologies (DBVT) Upgraded to Buy: What Does It Mean for the Stock?DBV Technologies (DBVT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Apr 14, 9:55 AM EDTWall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here's What You Should KnowThe mean of analysts' price targets for DBV Technologies (DBVT) points to a 79% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for DBV Technologies S.A. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.